Liminatus Pharma, Inc. Class A Common Stock
LIMN
Rank in Stocks
#32525
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical... Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Share Price
$2.99
Last synced: 2026-11-13
Market Cap
$1.42M
Change (1 day)
7.94%
Change (1 year)
182.08%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Category
Healthcare
EPS for Liminatus Pharma, Inc. Class A Common Stock (LIMN)
EPS as of June 2026 TTM: $-23.70
According to Liminatus Pharma, Inc. Class A Common Stock's latest financial reports, its current EPS (TTM) is $-23.70. At the end of 2025 the company had an EPS of $-21.50, a decrease compared to its 2024 EPS of $-20.00.
EPS history for Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-23.70 | 10.23% |
| 2025 | $-21.50 | 7.50% |
| 2024 | $-20.00 | 166.67% |
| 2023 | $-7.50 | 82.26% |
| 2022 | $-4.12 | -163.31% |
| 2021 | $6.50 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | -96.24% |
US
|
|
| $15.66 | -166.08% |
US
|
|
| $-7.07 | -70.17% |
US
|
|
| $-5.29 | -77.68% |
AU
|
|
| $12.73 | -153.72% |
BE
|
Questions about Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS)
What is Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS)?
Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) over the last twelve months is $-23.70, as of Jun 2026.
What was Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) in 2025?
In 2025, Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) was $-21.50, compared with $-20.00 in 2024.
How has Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) changed since 2021?
From 2021 to 2025, Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) was highest in 2021 ($6.50) and lowest in 2025 ($-21.50).
How does Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) compare with similar companies?
Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) ($-23.70) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.